<?xml version="1.0" encoding="UTF-8"?>
<p>Additionally, we need to expand the network of providers prescribing MOUD. Most infectious diseases and HIV physicians receive little to no formal training in the management of OUD and other SUDs. Training to identify and treat OUD and other SUDs should be increased in medical schools, nursing schools, physician assistant schools, residency programs, and within hospitals. While all infectious diseases and HIV physicians should become familiar with harm reduction principles and be able to counsel patients regarding safe injection practices, we need broader national support for physicians to comanage OUD, SUDs, and co-occurring infectious diseases. Lack of confidence has been identified as a major barrier preventing some physicians from integrating buprenorphine into their practice for the treatment of OUD [
 <xref rid="CIT0049" ref-type="bibr">49</xref>]. Warmlines, such as the one run by the Clinical Consultation Center at the University of California San Francisco, and videoconferencing-based learning communities such as Project ECHO, are excellent resources to provide support on a number of clinical aspects of disease management (
 <xref rid="T2" ref-type="table">Table 2</xref>) [
 <xref rid="CIT0044" ref-type="bibr">44</xref>]. Increasing funding for national and regional warmlines, telehealth-based learning communities, peer-to-peer mentoring programs, and other technical assistance programs such as the Opioid Response Network will help decrease barriers to providing substance use treatment. The Opioid Response Network is a network of experienced clinicians that is funded by the Substance Abuse Mental Health and Services Administration to provide technical assistance to improve access to substance use treatment.
</p>
